<p>(U138, T98G, C6) and HeLa cells at 3, 12, 24 and 48 h. HaCaT cell line was used as the reference. C stands for control cells treated with DMSO only.</p
Glioblastoma is the most common and deadly type of brain cancer. A common drug used to treat gliobla...
<p><b>A, Expression of <i>MGMT</i> gene in human malignant glioma cell lines.</b> RNA was isolated f...
The use of temozolomide (TMZ) has improved the prognosis for glioblastoma multiforme patients. Howev...
<p>U118 cell line treated with 250 μM (empty circle) and 500 μM (gray circle) of TMZ at 3, 6, 9, 12,...
Temozolomide (TMZ) is an oral alkylating chemotherapeutic agent that prolongs the survival of patien...
<p>Cell cycle phases distribution in human glioblastoma (T98G) versus non cancer (HaCaT) cell lines ...
<p>Representative images of (A) U87-MG and U–SC, and (B) L0627 morphology after 48 h treatment with ...
<p>The percentage of cells in each phase of the cell cycle in cancer (T98G) versus non cancer (HaCaT...
Glioblastoma leads to a fatal course within two years in more than two thirds of patients. An essent...
<p>MGMT-deficient U87 cells or U87 cells engineered to over-express MGMT (U87+MGMT) were incubated w...
Temozolomide (TMZ) is a drug of choice in glioblastoma treatment. Its therapeutic applications expan...
<p>(<b>A and B</b>) The human glioma cells LN229 (1×10<sup>5</sup> cells in 15 µl of DMEM medium) we...
<p>T98G cells were cultured for 3 days with CC-I and TMZ, and cytotoxicity was evaluated by SRB assa...
<p><b>A</b> LN18 cells were CAP treated once without medium; afterwards TMZ was applied consecutivel...
<p>Normal (HaCaT) and tumor cells (HeLa, T98G and U118)were treated with different TMZ concentration...
Glioblastoma is the most common and deadly type of brain cancer. A common drug used to treat gliobla...
<p><b>A, Expression of <i>MGMT</i> gene in human malignant glioma cell lines.</b> RNA was isolated f...
The use of temozolomide (TMZ) has improved the prognosis for glioblastoma multiforme patients. Howev...
<p>U118 cell line treated with 250 μM (empty circle) and 500 μM (gray circle) of TMZ at 3, 6, 9, 12,...
Temozolomide (TMZ) is an oral alkylating chemotherapeutic agent that prolongs the survival of patien...
<p>Cell cycle phases distribution in human glioblastoma (T98G) versus non cancer (HaCaT) cell lines ...
<p>Representative images of (A) U87-MG and U–SC, and (B) L0627 morphology after 48 h treatment with ...
<p>The percentage of cells in each phase of the cell cycle in cancer (T98G) versus non cancer (HaCaT...
Glioblastoma leads to a fatal course within two years in more than two thirds of patients. An essent...
<p>MGMT-deficient U87 cells or U87 cells engineered to over-express MGMT (U87+MGMT) were incubated w...
Temozolomide (TMZ) is a drug of choice in glioblastoma treatment. Its therapeutic applications expan...
<p>(<b>A and B</b>) The human glioma cells LN229 (1×10<sup>5</sup> cells in 15 µl of DMEM medium) we...
<p>T98G cells were cultured for 3 days with CC-I and TMZ, and cytotoxicity was evaluated by SRB assa...
<p><b>A</b> LN18 cells were CAP treated once without medium; afterwards TMZ was applied consecutivel...
<p>Normal (HaCaT) and tumor cells (HeLa, T98G and U118)were treated with different TMZ concentration...
Glioblastoma is the most common and deadly type of brain cancer. A common drug used to treat gliobla...
<p><b>A, Expression of <i>MGMT</i> gene in human malignant glioma cell lines.</b> RNA was isolated f...
The use of temozolomide (TMZ) has improved the prognosis for glioblastoma multiforme patients. Howev...
DOI
Add to ORKG